More Sophisticated Imaging Doesn't Necessarily Mean Better Outcomes in Ischemic HF But cardiac MRI, PET may still have value in some patients, per AIMI-HF trial Mar 09, 2023
Adaptive Pacemaker Fails in HFpEF Improvement in oxygen consumption response to physical exertion not observed in a small trial Mar 09, 2023
Virtual Care Team Optimized Heart Failure Medications During Hospitalization Trial shows modest effect with daily recommendations to the treating team Mar 07, 2023
Minimally Invasive Mitral Valve Surgery Earns Confidence in Expert Hands Decision for mini thoracotomy may rest on patient preference, expert operator availability Mar 06, 2023
Hunt for Hibernating Myocardium Doesn't Help PCI for Ischemic Cardiomyopathy REVIVED-BCIS2 challenges long-held beliefs about myocardial viability Mar 05, 2023
TEER Improves Quality of Life With Severe Tricuspid Regurgitation Pivotal trial is first to evaluate "impact of TR reduction on long-term effects on survival" Mar 04, 2023
Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
Omecamtiv Mecarbil for Heart Failure Turned Down by FDA End of the road for cardiac myosin activator Mar 01, 2023
ICI-Related Myocarditis Deaths Down With Tailored Non-Corticosteroid Strategy Paris center reports results of mechanical ventilation, JAK-STAT inhibition for some patients Feb 23, 2023
Arrival of TEER Has Helped Surgeons' Track Records Nationwide analysis of technology's effect since FDA approval 10 years ago Feb 06, 2023
Heart Failure Risk Lingers Long After Chemotherapy, Regardless of Dose Several-fold higher cardiovascular risk of anthracycline use persists over two decades Feb 03, 2023
Fixing Heart Failure Workforce Issues: Baby Steps Start This Year Pay, curriculum changes proposed to attract more doctors Jan 05, 2023
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggests Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
Skipping Antiplatelets Altogether Not Such a Bad Idea for Select TAVR Patients Promising results of letting some patients get away with no antithrombotic therapy Dec 14, 2022
Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors Say Rocky regulatory road lies ahead for the cardiac myosin activator Dec 13, 2022
Cardiac Contractility Drug Faces Headwinds at FDA Adcomm Safety, efficacy, dosing issues raised for omecamtiv mecarbil Dec 12, 2022
TAVR at 20: How Much Longer Will Medicare Mandate a Registry? Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
Heart Failure From Meth Use: Growing Beast Lurks in the Shadows Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth Rising prevalence of SLE in pregnancy, more frequent peripartum CV complications observed Nov 29, 2022
Early Cardiac Amyloidosis Still Bad News Without Treatment Observational study supports treating even asymptomatic patients Nov 16, 2022
Upfront ECMO Disappoints for Cardiogenic Shock High-cost procedure not yet justified as an early strategy Nov 07, 2022
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devices Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
Despite Exciting Newcomer Drugs, Uptake of HF Meds Still Meek Across Oceans U.S. not alone in slow initiation, low target-dose achievement, and early discontinuation Oct 14, 2022
Lower Entresto Doses Suffice in the Real World Reassuring findings for patients who don't tolerate the maximum ARNI dose Oct 10, 2022
FDA Approves At-Home Furosemide for Heart Failure Strong diuretic to become available outside the hospital setting Oct 10, 2022
Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmed Small randomized trial challenges conventional thinking about sodium Oct 05, 2022
Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons Heart pump placement plus anticoagulation suffice for patients, even those with Afib Oct 05, 2022
The Search Is On for Another Xeno Heart Transplant Recipient Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data Analyses continue to support wider adoption of dapagliflozin, researchers say Oct 03, 2022
Growing Calls to Marry HF Specialists With Cardiac Critical Care Cardiac ICU staffing issues require a multidisciplinary team approach, some say Oct 02, 2022
MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
